乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Geriatrics >

Parkinson's Disease

News, opinions and meeting coverage in geriatrics.

<乌鸦传媒>FDA Eyeing Patient-Reported Outcomes in Huntington's, Parkinson's

Some non-motor symptoms may be ideal 'PRO' candidates

<乌鸦传媒>Wise Buy? Focused Ultrasound Therapies

Exciting technology, but now sold to patients on slim supporting evidence

<乌鸦传媒>Novel Parkinson Therapies Highlighted at AAN Meeting

Early results with gene therapy, new carbidopa-levodopa formulation featured

<乌鸦传媒>Fraud Rounds: Four Retractions Tallied for PD Researcher Spared Jail

Faking co-author signatures, consent forms, and duplication adds up

<乌鸦传媒>ADHD Drug Fails to Boost Cognition in Parkinson's

But patients reported improvements in impulsivity, inattention

<乌鸦传媒>Quick Enrollment for STEADY-PD III Trial

Researchers enrolled 336 early Parkinson's patients within a year

<乌鸦传媒>Parkinson's GI Issues More Complex than Constipation

Study reveals IBS risk

<乌鸦传媒>Anxiety Overlooked in Parkinson's?

Longitudinal study finds 16% have baseline anxiety, 37% develop it over time

<乌鸦传媒>Physical Therapy Underused in Parkinson's

Only 11% of patients had used it in Medicare study

<乌鸦传媒>PD Patients Report Better Sleep With Rotigotine Tx

Patch form of dopamine agonist also lowered nighttime activity

<乌鸦传媒>Inhaled Levodopa May Bridge Parkinson's 'Off' Periods

Inhaler eased breakthrough motor symptoms between standard levodopa doses in an early study

<乌鸦传媒>Subcutaneous Apomorphine Gets Parkinson's Patient Moving Quickly

Most patients respond to injected drug within 20 minutes

<乌鸦传媒>Stroke Survivors May Face Greater Cancer Risk

Ischemic stroke increased likelihood of cancer within 2 years of the event.

<乌鸦传媒>FDA OKs Northera for Hypotension

The FDA has approved droxidopa (Northera) for the treatment of neurogenic orthostatic hypotension, a rare disease that results in a drop in blood pressure when patients try to stand up.

<乌鸦传媒>Droxidopa for OH Slammed by FDA Reviewers

SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.

<乌鸦传媒>Aricept Helps Cognition in Parkinson's

SYDNEY -- Parkinson's disease patients who have impaired cognition appeared to benefit from the Alzheimer's disease medicine donepezil (Aricept) with no detriment to their motor skills, researchers reported here.

<乌鸦传媒>Eye Tremors May Be Early Sign of Parkinson's

Eye tremors are pervasive in Parkinson's disease and could be an early warning sign of the neurodegenerative movement disorder, according to a case-control study.

<乌鸦传媒>Parkinson's Called Hidden Killer

Life expectancy for patients with Parkinson's disease is poorer than some previous studies have suggested, with barely one-third of patients surviving six years with the condition, researchers said.

<乌鸦传媒>Jumpy Legs in Parkinson's Likely Not RLS

Patients with early Parkinson's disease were more likely to have a movement disorder called leg motor restlessness than true restless legs syndrome, a study found.

<乌鸦传媒>Parkinson's Drug Doesn't Slow Disease Progress, FDA Staff Says

WASHINGTON -- Azilect (rasagiline), which is already approved to treat symptoms of Parkinson's disease, does not appear effective at slowing progression of the neurodegenerative disease, according to an FDA review.

<乌鸦传媒>FDA Blocks Sale of Supplements for Parkinson's and Alzheimer's

WASHINGTON -- The FDA filed a permanent injunction against two Minnesota companies that distributed amino acid products marketed as treatments for Parkinson's disease, Alzheimer's disease, and a number of other neurological disorders.